Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0E2FZ
|
|||
Former ID |
DIB005599
|
|||
Drug Name |
ICA-69673
|
|||
Synonyms |
ICA-069673; Ion channel modulators (epilepsy), ICAgen; Ion channel modulators, ICAgen/ArQule
Click to Show/Hide
|
|||
Indication | Pain [ICD-11: MG30-MG3Z] | Preclinical | [1] | |
Company |
Icagen Inc
|
|||
Structure |
Download2D MOL |
|||
Formula |
C11H6ClF2N3O
|
|||
Canonical SMILES |
C1=CC(=C(C=C1C(=O)NC2=CN=C(N=C2)Cl)F)F
|
|||
InChI |
1S/C11H6ClF2N3O/c12-11-15-4-7(5-16-11)17-10(18)6-1-2-8(13)9(14)3-6/h1-5H,(H,17,18)
|
|||
InChIKey |
IIBSHMFXVWTQSJ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 582323-16-8
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Voltage-gated potassium channel Kv7.2 (KCNQ2) | Target Info | Modulator | [2] |
Voltage-gated potassium channel Kv7.3 (KCNQ3) | Target Info | Modulator | [2] | |
KEGG Pathway | Cholinergic synapse | |||
Panther Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
Reactome | Voltage gated Potassium channels | |||
Interaction between L1 and Ankyrins | ||||
WikiPathways | Potassium Channels | |||
L1CAM interactions |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011004) | |||
REF 2 | Voltage-gated Potassium Channels as Therapeutic Drug Targets |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.